Pharmacielo Ltd (PCLO) - Total Liabilities
Based on the latest financial reports, Pharmacielo Ltd (PCLO) has total liabilities worth CA$23.57 Million CAD (≈ $17.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PCLO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Pharmacielo Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Pharmacielo Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PCLO current and non-current assets.
Pharmacielo Ltd Competitors by Total Liabilities
The table below lists competitors of Pharmacielo Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Home Pottery Public Company Limited
BK:HPT
|
Thailand | ฿93.80 Million |
|
Bell Copper Corp
V:BCU
|
Canada | CA$4.98 Million |
|
Longvie SA
BA:LONG
|
Argentina | AR$16.05 Billion |
|
DGB Group NV
AS:DGB
|
Netherlands | €14.38 Million |
|
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA
|
USA | $5.55 Million |
|
Corella Resources Ltd
AU:CR9
|
Australia | AU$694.23K |
|
Micro Digital Co. Ltd
KQ:305090
|
Korea | ₩38.62 Billion |
|
ATAM VALVES ORD (BSE)
NSE:ATAM
|
India | Rs200.51 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Pharmacielo Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See PCLO equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmacielo Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmacielo Ltd (2016–2024)
The table below shows the annual total liabilities of Pharmacielo Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$25.91 Million ≈ $18.74 Million |
+8.10% |
| 2023-12-31 | CA$23.97 Million ≈ $17.34 Million |
+28.01% |
| 2022-12-31 | CA$18.72 Million ≈ $13.54 Million |
+12.58% |
| 2021-12-31 | CA$16.63 Million ≈ $12.03 Million |
-6.45% |
| 2020-12-31 | CA$17.78 Million ≈ $12.86 Million |
+275.76% |
| 2019-12-31 | CA$4.73 Million ≈ $3.42 Million |
+20779.39% |
| 2018-12-31 | CA$22.66K ≈ $16.39K |
+79.19% |
| 2017-12-31 | CA$12.64K ≈ $9.15K |
-99.23% |
| 2016-12-31 | CA$1.65 Million ≈ $1.19 Million |
-- |
About Pharmacielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more